Literature DB >> 27825999

NAD and the aging process: Role in life, death and everything in between.

Claudia C S Chini1, Mariana G Tarragó1, Eduardo N Chini2.   

Abstract

Life as we know it cannot exist without the nucleotide nicotinamide adenine dinucleotide (NAD). From the simplest organism, such as bacteria, to the most complex multicellular organisms, NAD is a key cellular component. NAD is extremely abundant in most living cells and has traditionally been described to be a cofactor in electron transfer during oxidation-reduction reactions. In addition to participating in these reactions, NAD has also been shown to play a key role in cell signaling, regulating several pathways from intracellular calcium transients to the epigenetic status of chromatin. Thus, NAD is a molecule that provides an important link between signaling and metabolism, and serves as a key molecule in cellular metabolic sensoring pathways. Importantly, it has now been clearly demonstrated that cellular NAD levels decline during chronological aging. This decline appears to play a crucial role in the development of metabolic dysfunction and age-related diseases. In this review we will discuss the molecular mechanisms responsible for the decrease in NAD levels during aging. Since other reviews on this subject have been recently published, we will concentrate on presenting a critical appraisal of the current status of the literature and will highlight some controversial topics in the field. In particular, we will discuss the potential role of the NADase CD38 as a driver of age-related NAD decline.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Aging; CD38; Mitochondrial function; NAD(+); PARP; SIRTUINS

Mesh:

Substances:

Year:  2016        PMID: 27825999      PMCID: PMC5419884          DOI: 10.1016/j.mce.2016.11.003

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  151 in total

1.  Age-related loss of stress-induced nuclear proteasome activation is due to low PARP-1 activity.

Authors:  Edina Bakondi; Betul Catalgol; Istvan Bak; Tobias Jung; Perinur Bozaykut; Mehmet Bayramicli; Nesrin Kartal Ozer; Tilman Grune
Journal:  Free Radic Biol Med       Date:  2010-10-23       Impact factor: 7.376

Review 2.  The importance of NAMPT/NAD/SIRT1 in the systemic regulation of metabolism and ageing.

Authors:  S Imai; J Yoshino
Journal:  Diabetes Obes Metab       Date:  2013-09       Impact factor: 6.577

3.  Synthesis and degradation of cyclic ADP-ribose by NAD glycohydrolases.

Authors:  H Kim; E L Jacobson; M K Jacobson
Journal:  Science       Date:  1993-09-03       Impact factor: 47.728

4.  SIRT3 reverses aging-associated degeneration.

Authors:  Katharine Brown; Stephanie Xie; Xiaolei Qiu; Mary Mohrin; Jiyung Shin; Yufei Liu; Dan Zhang; David T Scadden; Danica Chen
Journal:  Cell Rep       Date:  2013-01-31       Impact factor: 9.423

5.  Enzymatic synthesis and degradation of nicotinate adenine dinucleotide phosphate (NAADP), a Ca(2+)-releasing agonist, in rat tissues.

Authors:  E N Chini; T P Dousa
Journal:  Biochem Biophys Res Commun       Date:  1995-04-06       Impact factor: 3.575

Review 6.  NAD(+) metabolism: Bioenergetics, signaling and manipulation for therapy.

Authors:  Yue Yang; Anthony A Sauve
Journal:  Biochim Biophys Acta       Date:  2016-06-29

Review 7.  Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases.

Authors:  Claudio Franceschi; Judith Campisi
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-06       Impact factor: 6.053

8.  Large supplements of nicotinic acid and nicotinamide increase tissue NAD+ and poly(ADP-ribose) levels but do not affect diethylnitrosamine-induced altered hepatic foci in Fischer-344 rats.

Authors:  T M Jackson; J M Rawling; B D Roebuck; J B Kirkland
Journal:  J Nutr       Date:  1995-06       Impact factor: 4.798

9.  PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation.

Authors:  Péter Bai; Carles Cantó; Hugues Oudart; Attila Brunyánszki; Yana Cen; Charles Thomas; Hiroyasu Yamamoto; Aline Huber; Borbála Kiss; Riekelt H Houtkooper; Kristina Schoonjans; Valérie Schreiber; Anthony A Sauve; Josiane Menissier-de Murcia; Johan Auwerx
Journal:  Cell Metab       Date:  2011-04-06       Impact factor: 27.287

10.  Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity.

Authors:  Daniel Kraus; Qin Yang; Dong Kong; Alexander S Banks; Lin Zhang; Joseph T Rodgers; Eija Pirinen; Thomas C Pulinilkunnil; Fengying Gong; Ya-chin Wang; Yana Cen; Anthony A Sauve; John M Asara; Odile D Peroni; Brett P Monia; Sanjay Bhanot; Leena Alhonen; Pere Puigserver; Barbara B Kahn
Journal:  Nature       Date:  2014-04-10       Impact factor: 49.962

View more
  72 in total

1.  A functional link between NAD+ homeostasis and N-terminal protein acetylation in Saccharomyces cerevisiae.

Authors:  Trevor Croft; Christol James Theoga Raj; Michelle Salemi; Brett S Phinney; Su-Ju Lin
Journal:  J Biol Chem       Date:  2018-01-09       Impact factor: 5.157

Review 2.  NAD+ metabolism and retinal degeneration (Review).

Authors:  Andreea Silvia Pîrvu; Ana Marina Andrei; Elena Camelia Stănciulescu; Ileana Monica Baniță; Cătălina Gabriela Pisoschi; Sanda Jurja; Radu Ciuluvica
Journal:  Exp Ther Med       Date:  2021-04-23       Impact factor: 2.447

3.  Reply to Moon and Minhas: Teasing apart NAD+ metabolism in inflammation: commentary on Zhou et al. (2016). Br J Pharmacol 173: 2352-2368.

Authors:  Pei Wang; Chao-Yu Miao
Journal:  Br J Pharmacol       Date:  2017-07-30       Impact factor: 8.739

4.  The copper-sensing transcription factor Mac1, the histone deacetylase Hst1, and nicotinic acid regulate de novo NAD+ biosynthesis in budding yeast.

Authors:  Christol James Theoga Raj; Trevor Croft; Padmaja Venkatakrishnan; Benjamin Groth; Gagandeep Dhugga; Timothy Cater; Su-Ju Lin
Journal:  J Biol Chem       Date:  2019-02-13       Impact factor: 5.157

Review 5.  Interplay between NAD+ and acetyl‑CoA metabolism in ischemia-induced mitochondrial pathophysiology.

Authors:  Nina Klimova; Aaron Long; Susana Scafidi; Tibor Kristian
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-09-24       Impact factor: 5.187

Review 6.  Rho GTPase effectors and NAD metabolism in cancer immune suppression.

Authors:  Mahmoud Chaker; Audrey Minden; Suzie Chen; Robert H Weiss; Eduardo N Chini; Amit Mahipal; Asfar S Azmi
Journal:  Expert Opin Ther Targets       Date:  2017-12-10       Impact factor: 6.902

7.  Quantitative Analysis of NAD Synthesis-Breakdown Fluxes.

Authors:  Ling Liu; Xiaoyang Su; William J Quinn; Sheng Hui; Kristin Krukenberg; David W Frederick; Philip Redpath; Le Zhan; Karthikeyani Chellappa; Eileen White; Marie Migaud; Timothy J Mitchison; Joseph A Baur; Joshua D Rabinowitz
Journal:  Cell Metab       Date:  2018-05-01       Impact factor: 27.287

8.  A multiscale analysis in CD38-/- mice unveils major prefrontal cortex dysfunctions.

Authors:  Lora L Martucci; Muriel Amar; Remi Chaussenot; Gabriel Benet; Oscar Bauer; Antoine de Zélicourt; Anne Nosjean; Jean-Marie Launay; Jacques Callebert; Catherine Sebrié; Antony Galione; Jean-Marc Edeline; Sabine de la Porte; Philippe Fossier; Sylvie Granon; Cyrille Vaillend; José-Manuel Cancela
Journal:  FASEB J       Date:  2019-03-07       Impact factor: 5.191

9.  NAD metabolism in aging and cancer.

Authors:  John Wr Kincaid; Nathan A Berger
Journal:  Exp Biol Med (Maywood)       Date:  2020-06-05

10.  N-terminal protein acetylation by NatB modulates the levels of Nmnats, the NAD+ biosynthetic enzymes in Saccharomyces cerevisiae.

Authors:  Trevor Croft; Padmaja Venkatakrishnan; Christol James Theoga Raj; Benjamin Groth; Timothy Cater; Michelle R Salemi; Brett Phinney; Su-Ju Lin
Journal:  J Biol Chem       Date:  2020-04-16       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.